492 related articles for article (PubMed ID: 27491217)
1. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
3. Krabbe disease: New hope for an old disease.
Bradbury AM; Bongarzone ER; Sands MS
Neurosci Lett; 2021 May; 752():135841. PubMed ID: 33766733
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
5. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.
Qin EY; Hawkins-Salsbury JA; Jiang X; Reddy AS; Farber NB; Ory DS; Sands MS
Mol Genet Metab; 2012 Sep; 107(1-2):186-96. PubMed ID: 22704480
[TBL] [Abstract][Full Text] [Related]
7. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
11. Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
Weinstock NI; Shin D; Dhimal N; Hong X; Irons EE; Silvestri NJ; Reed CB; Nguyen D; Sampson O; Cheng YC; Lau JTY; Bongarzone ER; Kofler J; Escolar ML; Gelb MH; Wrabetz L; Feltri ML
Neuron; 2020 Jul; 107(1):65-81.e9. PubMed ID: 32375064
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.
Feltri ML; Weinstock NI; Favret J; Dhimal N; Wrabetz L; Shin D
Glia; 2021 Oct; 69(10):2309-2331. PubMed ID: 33851745
[TBL] [Abstract][Full Text] [Related]
13. Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.
Rafi MA; Rao HZ; Luzi P; Wenger DA
Mol Ther; 2015 Nov; 23(11):1681-1690. PubMed ID: 26329589
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
16. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
17. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
19. Treatment for Krabbe's disease: Finding the combination.
Mikulka CR; Sands MS
J Neurosci Res; 2016 Nov; 94(11):1126-37. PubMed ID: 27638598
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration.
Kreher C; Favret J; Weinstock NI; Maulik M; Hong X; Gelb MH; Wrabetz L; Feltri ML; Shin D
PLoS Biol; 2022 Jul; 20(7):e3001661. PubMed ID: 35789331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
